http://purl.org/np/RArlK6lta2ydavWQxhyuN_oSqAlLi3Vj6eeYfJ9o_QpJw
.trig | .trig.txt | .jelly | .jelly.txt
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix ns1: <https://w3id.org/np/o/ntemplate/> .
@prefix this: <http://purl.org/np/RArlK6lta2ydavWQxhyuN_oSqAlLi3Vj6eeYfJ9o_QpJw> .
@prefix sub: <http://purl.org/np/RArlK6lta2ydavWQxhyuN_oSqAlLi3Vj6eeYfJ9o_QpJw#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
<http://purl.obolibrary.org/obo/DOID_3892> biolink:category biolink:Disease .
sub:association a rdf:Statement;
rdf:object <http://purl.obolibrary.org/obo/DOID_3892>;
rdf:predicate biolink:treats;
rdf:subject <https://identifiers.org/drugbank:DB00040>;
rdfs:label "\"GVOKE is contraindicated in patients with: Pheochromocytoma [ see Warnings and Precautions ( 5.1 Insulinoma [ see Warnings and Precautions ( 5.2 Known hypersensitivity to glucagon or to any of the excipients in GVOKE. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [ see Warnings and Precautions ( 5.3 Pheochromocytoma ( 4 Insulinoma ( 4 Known hypersensitivity to glucagon or to any of the excipients ( 4\"";
biolink:provided_by <https://w3id.org/um/NeuroDKG>;
biolink:relation schema:MedicalContraindication .
<https://identifiers.org/drugbank:DB00040> biolink:category biolink:Drug .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "PKNiZyPm62x1o+yw2vKVT64+P/Iyaca1wAuMpZhrDNHx8HtWSR5hpw7Z0EC6nX4RP2B10VnWwUri8AS+UoGw4w26/4XKVfyirbDWgY5a9uuiIcB5cglSmqWoEvORfNChSIFaKrhJbD/P6wv6WscsfEGvTYOOzyvS4tqOMcbex2k=";
npx:hasSignatureTarget this: .
this: dct:created "2021-08-25T13:32:36.032+02:00"^^xsd:dateTime;
dct:creator orcid:0000-0002-1468-3557;
ns1:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
ns1:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
ns1:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}